Medicare 2.0 - a vision for the future of America’s health insurance plan

21 November 2022 - Medicare is one of the great successes in American social policy. It provides universal health insurance to ...

Read more →

Getting the price right: lessons for Medicare price negotiation from peer countries

9 November 2022 - The US pays more for brand-name prescription drugs than any other country and new legislation from August ...

Read more →

Independent review into Medicare compliance

5 November 2022 - The Albanese Government has appointed respected health economist Dr Pradeep Philip to conduct an independent review into ...

Read more →

Budget October 2022–23: strengthening Medicare

25 October 2022 - The Australian Government’s 2022-23 Budget begins the task of strengthening Medicare after a decade of cuts and ...

Read more →

‘Distressed and appalled’: eye doctor sees red at overcharging by peers

25 October 2022 - Central Queensland eye surgeon David Kitchen has had enough of long-term, rampant rorting by some of ...

Read more →

Drug makers look to limit Medicare’s new power to negotiate lower drug prices

20 October 2022 - Industry tries to ease impact of Inflation Reduction Act, as regulators start to implement the law. ...

Read more →

Senator Collins, Representative Eshoo decry Medicare coverage rejection of Alzheimer’s drugs

18 October 2022 - “It’s not CMS’ job to deny the use under the Medicare program of an FDA-approved drug.” – ...

Read more →

Calls for TGA to withdraw Covid drug approval

17 October 2022 - The medicines regulator is facing calls to withdraw its provisional approval for the antiviral drug molnupiravir ...

Read more →

Medicare rorts expose inflated bulk billing rates

18 October 2022 - Systemic rorting of Medicare is artificially inflating official statistics that claim almost nine out of 10 ...

Read more →

Medicare reports

17 October 2022 - Minister for Health and Aged Care, Mark Butler has issued the following statement regarding Medicare reporting. ...

Read more →

Impending relief for Medicare beneficiaries - the Inflation Reduction Act

15 October 2022 - For many Medicare beneficiaries, the Inflation Reduction Act will reduce out of pocket spending for retail prescription ...

Read more →

COVID-19: nirmatrelvir/ritonavir reduces the risk of a severe course in patients at risk

4 October 2022 - However, due to contra-indications and interactions, the combination of active ingredients is not suitable for all patients ...

Read more →

Medicare lays out the bureaucracy it will need to negotiate drug prices

29 September 2022 - New documents outline how Medicare is planning to build out a sizeable new bureaucratic infrastructure to ...

Read more →

Half of GPs say staying open is financially unsustainable as Medicare rebate fails

28 September 2022 - Staying in general practice is financially unsustainable for almost half of the nation’s GPs due to ...

Read more →

Growing financial burden from high-cost targeted oral anti-cancer medicines among Medicare beneficiaries with cancer

13 September 2022 - The rapidly rising costs of targeted oral anti-cancer medicines raise concerns over their affordability.  ...

Read more →